-
Breakthrough technology for the first time combines the benefits of a bipolar clamp with the flexibility of an endoscopically guided probe.
-
First study of its kind using multiple temperature-controlled radiofrequency devices to assess the safety and effectiveness of surgical ablation in treating non-paroxysmal atrial fibrillation.
-
San Ramon, California. --- December 5th --- Estech, a leader in minimally invasive cardiac surgery, announced today that the first three patients have been enrolled in the HISTORICAF European multi-center staged hybrid ablation clinical study. Ten centers will participate in the study which is expected to enroll over 100 patients in Italy, Germany, the United Kingdom, France, and Poland.
-
Ann Arbor, Michigan – November 11, 2011 -Terumo Cardiovascular Systems announced today that it has entered into an exclusive agreement with Estech Corporation for the distribution of Estech’s CABG stabilization and access products in the US. Effective immediately, Terumo will exclusively market, sell and distribute Estech’s complete line of CABG products for off-pump, on-pump and endocab...
-
Milan, Italy, 19 July 2011 – Sorin Group, (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, has purchased the cannulae product line from Estech. The purchase includes all Estech cannulae portfolio supporting minimally invasive and traditional cardiac surgery procedures.
-
San Ramon, Calif. --- December 7, 2010 --- Estech announced today that it has completed $8.5 million in equity financing to pursue further development of its minimally invasive cardiac ablation surgical platform. Investors participating in the financing include Saints Capital Everest, Telegraph Hill Partners, NBGI Ventures and Tullis Health Investors. Over the last two years, Estech has raised...
-
New Technology Combines Unprecedented Lesion Effectiveness with Ergonomic Ease of Use
-
San Ramon, Calif. -- September 22, 2009 -- Endoscopic Technologies, Inc. (d.b.a. Estech®), a leading provider of minimally invasive cardiac surgery devices and disposables, today announced the appointment of Andrew S. Wechsler, M.D., as its medical director.
-
Starting in late 2008, the United States Department of Justice (DOJ) undertook a broad investigation of many companies in the field of surgical ablation for alleged improper marketing and inappropriate conduct related to reimbursement and other issues.
-
New Financing to Support Continued Expansion of Sales, Marketing and Product Development
